A Model for Dissemination and Independent Analysis of Industry Data

被引:37
作者
Krumholz, Harlan M. [1 ,2 ,4 ,5 ]
Ross, Joseph S. [3 ]
机构
[1] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA
[2] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT 06510 USA
[4] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA
[5] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 306卷 / 14期
关键词
PLACEBO;
D O I
10.1001/jama.2011.1459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1593 / 1594
页数:2
相关论文
共 8 条
[1]   Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials [J].
Eyding, Dirk ;
Lelgemann, Monika ;
Grouven, Ulrich ;
Haerter, Martin ;
Kromp, Mandy ;
Kaiser, Thomas ;
Kerekes, Michaela F. ;
Gerken, Martin ;
Wieseler, Beate .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :816
[2]   The role of litigation in defining drug risks [J].
Kesselheim, Aaron S. ;
Avorn, Jerry .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03) :308-311
[3]   The strengths and limitations of meta-analyses based on aggregate data [J].
Lyman G.H. ;
Kuderer N.M. .
BMC Medical Research Methodology, 5 (1)
[4]  
Marciniak TA, 2010, MEMORANDUM CARDIOVAS
[5]   Persistence of Cardiovascular Risk After Rofecoxib Discontinuation [J].
Ross, Joseph S. ;
Madigan, David ;
Konstam, Marvin A. ;
Egilman, David S. ;
Krumholz, Harlan M. .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (22) :2035-2036
[6]   Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data Lessons for Postmarket Pharmaceutical Safety Surveillance [J].
Ross, Joseph S. ;
Madigan, David ;
Hill, Kevin P. ;
Egilman, David S. ;
Wang, Yongfei ;
Krumholz, Harlan M. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (21) :1976-1985
[7]   Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis [J].
Ross, Joseph S. ;
Mulvey, Gregory K. ;
Hines, Elizabeth M. ;
Nissen, Steven E. ;
Krumholz, Harlan M. .
PLOS MEDICINE, 2009, 6 (09)
[8]  
Winslow R, 2011, WALL STREET J 0802